Gan & Lee Pharmaceuticals 2024 Annual Report with Sustainability Disclosures
Company: Gan & Lee Pharmaceuticals
Sector: Manufacturing
Country: China
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 281
The report describes the company's 2024 operating revenue of RMB 3,045.35 million, continued investment in R&D totaling RMB 645,752,366.86, and carbon-reduction measures that reduced emissions by 16,022.8628 tons.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.